Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy

Author： Srivastava Punit K Dastidar Sunanda G Ray Abhijit

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.7, 2007-06, pp. : 1069-1078

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in drug delivery: is triple therapy the future for the treatment of chronic obstructive pulmonary disease?

By Salama Rania O Young Paul M Rogueda Philippe Lallement Arthur Iliev Ilian Traini Daniela

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1913-1932

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities

By Hersh Craig P

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 237-247

Future Medicine

Access to resources Recommend Favorite

Dysfunction of Pulmonary Vascular Endothelium in Chronic Obstructive Pulmonary Disease: Basic Considerations for Future Drug Development

Current Drug Metabolism, Vol. 9, Iss. 7, 2008-09 ,pp. : 661-667

Bentham Science Publishers

Access to resources Recommend Favorite

Inhaled therapy for stable chronic obstructive pulmonary disease

By Antoniu Sabina A Mihaescu Traian Donner &

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 777-785

Informa Healthcare

Access to resources Recommend Favorite

Common and Uncommon Features of Rheumatoid Arthritis and Chronic Obstructive Pulmonary Disease: Clues to a Future Therapy

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 85-92

Bentham Science Publishers

Access to resources Recommend Favorite